Cumberland Gross Profit from 2010 to 2024

CPIX Stock

USD 1.14 0.06 5.00%

Cumberland Pharmaceuticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Cumberland Pharmaceuticals makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2006-03-31

Previous Quarter

7 M

Current Value

7.8 M

Quarterly Volatility

2.1 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Cumberland Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cumberland Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.1 M, Interest Expense of 701.3 K or Selling General Administrative of 8.9 M, as well as many indicators such as Price To Sales Ratio of 0.61, Dividend Yield of 0.0 or PTB Ratio of 0.82. Cumberland financial statements analysis is a perfect complement when working with Cumberland Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Cumberland Pharmaceuticals Correlation against competitors.

For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.

Latest Cumberland Pharmaceuticals' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Cumberland Pharmaceuticals over the last few years. Gross profit is a required income statement account that reflects total revenue of Cumberland Pharmaceuticals minus its cost of goods sold. It is profit before Cumberland Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Cumberland Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cumberland Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 32.89 M

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Cumberland Gross Profit Regression Statistics

	Arithmetic Mean	30,940,143
	Geometric Mean	29,614,148
	Coefficient Of Variation	26.28
	Mean Deviation	5,505,318
	Median	31,848,706
	Standard Deviation	8,130,651
	Sample Variance	66.1T
	Range	35.6M
	R-Value	0.07
	Mean Square Error	70.9T
	R-Squared	0
	Significance	0.81
	Slope	120,910
	Total Sum of Squares	925.5T

Cumberland Gross Profit History

	2024	33.9 M
	2023	33.5 M
	2022	32.9 M
	2021	27.2 M
	2020	28.8 M
	2019	27 M
	2018	33.4 M

Other Fundumenentals of Cumberland Pharmaceuticals

Gross Profit Margin

Cumberland Pharmaceuticals Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Long Term Debt	Common Stock	Property Plant Equipment	Net Tangible Assets	Long Term Debt Total	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.64	0.87	-0.23	0.39	0.33	0.49	0.43	0.75	0.19	0.66	0.4	0.76	0.22	-0.31	0.27	0.1	0.02	-0.15	-0.01
Total Stockholder Equity	0.64		0.53	-0.82	0.85	-0.38	-0.18	-0.42	0.94	0.3	-0.05	-0.41	0.91	-0.3	0.45	-0.54	0.05	0.49	0.51	0.25
Current Deferred Revenue	0.87	0.53		-0.1	0.14	0.5	0.51	0.4	0.6	0.11	0.57	0.32	0.68	0.23	-0.47	0.25	0.19	-0.36	-0.39	-0.36
Net Debt	-0.23	-0.82	-0.1		-0.85	0.74	0.4	0.7	-0.74	-0.36	0.48	0.64	-0.75	0.52	-0.81	0.73	0.0	-0.65	-0.8	-0.55
Retained Earnings	0.39	0.85	0.14	-0.85		-0.63	-0.35	-0.54	0.74	0.43	-0.13	-0.52	0.72	-0.44	0.69	-0.64	0.0	0.81	0.83	0.69
Accounts Payable	0.33	-0.38	0.5	0.74	-0.63		0.73	0.84	-0.23	0.0	0.71	0.79	-0.25	0.58	-0.95	0.82	0.33	-0.71	-0.87	-0.65
Net Receivables	0.49	-0.18	0.51	0.4	-0.35	0.73		0.79	-0.02	0.1	0.68	0.7	0.08	0.53	-0.72	0.63	0.16	-0.54	-0.63	-0.3
Total Liab	0.43	-0.42	0.4	0.7	-0.54	0.84	0.79		-0.22	-0.13	0.84	0.96	-0.17	0.62	-0.89	0.95	0.06	-0.55	-0.79	-0.31
Total Current Assets	0.75	0.94	0.6	-0.74	0.74	-0.23	-0.02	-0.22		0.3	0.05	-0.17	0.91	-0.29	0.32	-0.31	0.1	0.43	0.38	0.21
Short Term Debt	0.19	0.3	0.11	-0.36	0.43	0.0	0.1	-0.13	0.3		0.05	-0.09	0.2	-0.19	0.18	-0.16	0.83	0.37	0.41	0.32
Intangible Assets	0.66	-0.05	0.57	0.48	-0.13	0.71	0.68	0.84	0.05	0.05		0.75	0.09	0.47	-0.77	0.68	0.11	-0.28	-0.53	-0.16
Long Term Debt	0.4	-0.41	0.32	0.64	-0.52	0.79	0.7	0.96	-0.17	-0.09	0.75		-0.19	0.6	-0.82	0.97	0.1	-0.44	-0.72	-0.28
Common Stock	0.76	0.91	0.68	-0.75	0.72	-0.25	0.08	-0.17	0.91	0.2	0.09	-0.19		-0.17	0.28	-0.31	-0.07	0.28	0.32	0.26
Property Plant Equipment	0.22	-0.3	0.23	0.52	-0.44	0.58	0.53	0.62	-0.29	-0.19	0.47	0.6	-0.17		-0.59	0.61	-0.09	-0.4	-0.63	-0.36
Net Tangible Assets	-0.31	0.45	-0.47	-0.81	0.69	-0.95	-0.72	-0.89	0.32	0.18	-0.77	-0.82	0.28	-0.59		-0.84	-0.17	0.78	0.93	0.66
Long Term Debt Total	0.27	-0.54	0.25	0.73	-0.64	0.82	0.63	0.95	-0.31	-0.16	0.68	0.97	-0.31	0.61	-0.84		0.07	-0.53	-0.79	-0.33
Short Long Term Debt	0.1	0.05	0.19	0.0	0.0	0.33	0.16	0.06	0.1	0.83	0.11	0.1	-0.07	-0.09	-0.17	0.07		-0.02	0.01	-0.18
Net Invested Capital	0.02	0.49	-0.36	-0.65	0.81	-0.71	-0.54	-0.55	0.43	0.37	-0.28	-0.44	0.28	-0.4	0.78	-0.53	-0.02		0.89	0.78
Net Working Capital	-0.15	0.51	-0.39	-0.8	0.83	-0.87	-0.63	-0.79	0.38	0.41	-0.53	-0.72	0.32	-0.63	0.93	-0.79	0.01	0.89		0.78
Capital Stock	-0.01	0.25	-0.36	-0.55	0.69	-0.65	-0.3	-0.31	0.21	0.32	-0.16	-0.28	0.26	-0.36	0.66	-0.33	-0.18	0.78	0.78

Click cells to compare fundamentals

About Cumberland Pharmaceuticals Financial Statements

Cumberland Pharmaceuticals investors use historical fundamental indicators, such as Cumberland Pharmaceuticals' Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cumberland Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	33.5 M	33.9 M
Gross Profit Margin	0.85	0.94

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

300825	Iat Automobile Technology
600666	Aurora Optoelectronics Co
000678	Xiangyang Automobile Bearing

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC